162 related articles for article (PubMed ID: 34855235)
1. Neoplastic synovial lining cells that coexpress podoplanin and CD90 overproduce CSF-1, driving tenosynovial giant cell tumor.
Chandler AC; Yakoub M; Fujiwara T; Donlin LT; Purdue PE; Healey JH
J Orthop Res; 2022 Aug; 40(8):1918-1925. PubMed ID: 34855235
[TBL] [Abstract][Full Text] [Related]
2. Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumor.
Tap WD; Healey JH
Tumour Biol; 2022; 44(1):239-248. PubMed ID: 36502356
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
Front Immunol; 2020; 11():613975. PubMed ID: 33679701
[TBL] [Abstract][Full Text] [Related]
4. Tenosynovial giant cell tumor of the suboccipital region - A rare, benign neoplasm in this location.
Singh R; Stienen MN; Ganjoo K; Kolahi KS; Cayrol R; Charville GW; Born DE; Zygourakis CC
J Clin Neurosci; 2020 Aug; 78():413-415. PubMed ID: 32631721
[TBL] [Abstract][Full Text] [Related]
5. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Benner B; Good L; Quiroga D; Schultz TE; Kassem M; Carson WE; Cherian MA; Sardesai S; Wesolowski R
Drug Des Devel Ther; 2020; 14():1693-1704. PubMed ID: 32440095
[TBL] [Abstract][Full Text] [Related]
6. Malignant Tenosynovial Giant Cell Tumor: The True "Synovial Sarcoma?" A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes.
Al-Ibraheemi A; Ahrens WA; Fritchie K; Dong J; Oliveira AM; Balzer B; Folpe AL
Mod Pathol; 2019 Feb; 32(2):242-251. PubMed ID: 30206409
[TBL] [Abstract][Full Text] [Related]
7. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis.
Ekwall AK; Eisler T; Anderberg C; Jin C; Karlsson N; Brisslert M; Bokarewa MI
Arthritis Res Ther; 2011 Mar; 13(2):R40. PubMed ID: 21385358
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.
Croft AP; Naylor AJ; Marshall JL; Hardie DL; Zimmermann B; Turner J; Desanti G; Adams H; Yemm AI; Müller-Ladner U; Dayer JM; Neumann E; Filer A; Buckley CD
Arthritis Res Ther; 2016 Nov; 18(1):270. PubMed ID: 27863512
[TBL] [Abstract][Full Text] [Related]
9. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular Tenosynovial Giant Cell Tumor Harboring a Novel
Mejbel H; Siegal GP; Wei S
Int J Surg Pathol; 2022 May; 30(3):335-338. PubMed ID: 34657489
[TBL] [Abstract][Full Text] [Related]
11. Abundant lubricin expression suggests a link between synoviocytes, synovial tumors, and myxomas.
Solka KA; Schmid TM; Miller IJ
Histol Histopathol; 2016 Oct; 31(10):1131-41. PubMed ID: 26924731
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Podoplanin in Synovial Tissues in Rheumatoid Arthritis Patients Using Biologic or Conventional Disease-Modifying Anti-Rheumatic Drugs.
Takakubo Y; Oki H; Naganuma Y; Saski K; Sasaki A; Tamaki Y; Suran Y; Konta T; Takagi M
Curr Rheumatol Rev; 2017; 13(1):72-78. PubMed ID: 27030253
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel.
Suzuki T; Takakubo Y; Oki H; Liu X; Honma R; Naganuma Y; Goodman SB; Kaneko MK; Kato Y; Takagi M
Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):12-19. PubMed ID: 29377768
[TBL] [Abstract][Full Text] [Related]
14. Tenosynovial giant cell tumor.
Kager M; Kager R; Fałek P; Fałek A; Szczypiór G; Niemunis-Sawicka J; Rzepecka-Wejs L; Starosławska E; Burdan F
Folia Med Cracov; 2022; 62(2):93-107. PubMed ID: 36256897
[TBL] [Abstract][Full Text] [Related]
15. Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors.
van IJzendoorn DGP; Matusiak M; Charville GW; Spierenburg G; Varma S; Colburg DRC; van de Sande MAJ; van Langevelde K; Mohler DG; Ganjoo KN; Bui NQ; Avedian RS; Bovée JVMG; Steffner R; West RB; van de Rijn M
Clin Cancer Res; 2022 Nov; 28(22):4934-4946. PubMed ID: 36007098
[TBL] [Abstract][Full Text] [Related]
16. Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic implications.
Boland JM; Folpe AL; Hornick JL; Grogg KL
Am J Surg Pathol; 2009 Aug; 33(8):1225-9. PubMed ID: 19542874
[TBL] [Abstract][Full Text] [Related]
17. Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS; Katiyar V; Dy P; Singh V
Hematol Oncol Stem Cell Ther; 2023 May; 16(4):307-315. PubMed ID: 37363972
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin2 Inhibits the Apoptosis and Facilitates the Proliferation of Fibroblast-like Synoviocytes in Diffuse-type Tenosynovial Giant Cell Tumor.
Cao C; Zhang Y; Cheng J; Wu F; Niu X; Hu X; Duan X; Fu X; Zhang J; Zhang X; Ao Y
Cancer Genomics Proteomics; 2021; 18(3 Suppl):461-470. PubMed ID: 33994368
[TBL] [Abstract][Full Text] [Related]
19. Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
Robert M; Farese H; Miossec P
Front Immunol; 2022; 13():820046. PubMed ID: 35265077
[TBL] [Abstract][Full Text] [Related]
20. Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA; Chawla PA
Anticancer Agents Med Chem; 2021; 21(12):1510-1519. PubMed ID: 33143617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
